Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Goudsmit

Showing results (191-200 of 424) with videos related to

Pageof 43
Sort By:
AIDS Research and Human Retroviruses|November 1, 1992
Characterization of the specificity of the human antibody response to the V3 neutralization domain of HIV-1G Zwart, T F Wolfs, M Valk, et al.
AIDS (London, England)|August 1, 1992
Development of HIV-1 group-specific neutralizing antibodies after seroconversionA McKnight, P R Clapham, J Goudsmit, et al.
Journal of Medical Virology|June 1, 1991
Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The NetherlandsJ A van den Hoek, E J Al, J G Huisman, et al.
Tropical and Geographical Medicine|September 1, 1986
Hemorrhagic fever virus infections in an isolated rainforest area of central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in AfricaF W Van der Waals, K L Pomeroy, J Goudsmit, et al.
Journal of Clinical Microbiology|April 28, 2001
One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes A, B, and C and circulating recombinant forms AE and AGM P de Baar, E C Timmermans, M Bakker, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 18, 2001
[Ethiopia-Netherlands AIDS research project]E J Sanders, T F de Wit, A L Fontanet, et al.
AIDS (London, England)|January 1, 1990
Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversionV J Teeuwsen, K H Siebelink, F de Wolf, et al.
AIDS (London, England)|March 29, 2001
Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infectionN H Dukers, J Goudsmit, J B de Wit, et al.
AIDS Research and Human Retroviruses|December 1, 1994
Conserved V3 loop sequences and transmission of human immunodeficiency virus type 1E G Shpaer, E L Delwart, C L Kuiken, et al.
AIDS Research and Human Retroviruses|October 1, 1989
Serum reactivity to HIV-1 accessory gene products distinguishes East African from West African HIV strains as infecting agentJ Goudsmit, J T Dekker, C A Boucher, et al.
Pageof 43

Showing results (191-200 of 424) with videos related to

Sort By:
Pageof 43
AIDS Research and Human Retroviruses|November 1, 1992
Characterization of the specificity of the human antibody response to the V3 neutralization domain of HIV-1G Zwart, T F Wolfs, M Valk, et al.
AIDS (London, England)|August 1, 1992
Development of HIV-1 group-specific neutralizing antibodies after seroconversionA McKnight, P R Clapham, J Goudsmit, et al.
Journal of Medical Virology|June 1, 1991
Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The NetherlandsJ A van den Hoek, E J Al, J G Huisman, et al.
Tropical and Geographical Medicine|September 1, 1986
Hemorrhagic fever virus infections in an isolated rainforest area of central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in AfricaF W Van der Waals, K L Pomeroy, J Goudsmit, et al.
Journal of Clinical Microbiology|April 28, 2001
One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes A, B, and C and circulating recombinant forms AE and AGM P de Baar, E C Timmermans, M Bakker, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 18, 2001
[Ethiopia-Netherlands AIDS research project]E J Sanders, T F de Wit, A L Fontanet, et al.
AIDS (London, England)|January 1, 1990
Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversionV J Teeuwsen, K H Siebelink, F de Wolf, et al.
AIDS (London, England)|March 29, 2001
Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infectionN H Dukers, J Goudsmit, J B de Wit, et al.
AIDS Research and Human Retroviruses|December 1, 1994
Conserved V3 loop sequences and transmission of human immunodeficiency virus type 1E G Shpaer, E L Delwart, C L Kuiken, et al.
AIDS Research and Human Retroviruses|October 1, 1989
Serum reactivity to HIV-1 accessory gene products distinguishes East African from West African HIV strains as infecting agentJ Goudsmit, J T Dekker, C A Boucher, et al.
Pageof 43